Ideas & Insights

With IT often viewed as expensive, it can be a quick target for cost-cutting. Learn how unplanned reductions can be harmful to the business.

Information technology is valuable to business leaders and their companies, but there must be an investment in people for true success.

Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.

While an audit and quality of earnings analysis are different, they are complementary and can provide stronger insight within a transaction.

While 2021 may turn into a feeding frenzy for private equity, longer-term investors can remain as selective as they’ve always been.

SPACs have grown in popularity recently as a means of going public. Learn why high-growth companies are using this method.

An in-depth discussion among PE leaders addressing the effects of COVID-19, technology and a disrupted supply chain on U.S. manufacturing.

After a quiet period set off by the coronavirus pandemic, private equity deal activity in the United States surged through mid-November

Smart and effective use of data and analytics helps improve business performance, cut costs, and maximize profits.

Joint venture between an airline and private equity firm combined service offerings to create a premier aviation-handling provider

An in-depth discussion among private equity leaders addressing the winners and losers in the food and beverage industry during COVID-19.

Join RSM and Ravinia Capital on September 10 to review the outlook for acquisitions, lending and distressed deal activity.

How are businesses leveraging digital transformation to successfully navigate through and grow out of the current crisis.

Learn the key analyses to evaluate a TMT business, providing insight into the potential upsides and pitfalls of a transaction.

IT due diligence can mitigate operational risks and identify investments needed to achieve the revenue objectives in the investment thesis.

Starting the working capital mechanism discussion at the onset of a transaction is more important than ever. Learn more here.

RSM launches RSM launches M&A360™ An outcome-driven framework focused on enhancing value creation throughout the life of an investment

COVID-19 EBITDA analyses are imperative. A mutual understanding between a buyer and seller of the financial model assumptions is key

An in-depth discussion addressing health care deals during COVID-19, the surge of telemedicine and the business of hospitals.

We are in the midst of a pandemic; RSM offers perspectives and insights on how COVID-19 has impacted M&A in the TMT industry.